Fact CheckerSign in

NCT06582199Recruiting

Precision Medicine in Alzheimer's Disease : Integration of Resilience Metrics and Risk Factors - Validation Cohort BioCogBank-AD

Precision Medicine in Alzheimer's Disease: Integration of Resilience Metrics and Risk Factors - Validation Cohort BioCogBank-AD

Source: ClinicalTrials.gov · Last updated 27 Mar 2026

Brief summary (registry, in English)

BioCogBankAD aims at building a prospective clinical practice cohort of 244 patients with biologically confirmed mild cognitive impairment due to Alzheimer's Disease (AD) or mild AD in order to validate data regarding markers of resilience toward AD pathophysiological process discovered in an upstream project called AD-Resilience.

Status (registry)
Recruiting
Study type
Interventional
Enrollment
244 (estimated)
First submitted
23 Jul 2024
Start date
31 Oct 2024
Primary completion date
Sept 2027
Lead sponsor
Assistance Publique - Hôpitaux de Paris
NCT number
NCT06582199

What you commit to

  • Study type: Interventional
  • Planned participants: 244
  • From 31 Oct 2024 to the primary completion date, Sept 2027
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • Other cause of dementia

Other

  • Participation in an AD therapeutic clinical trial
  • Protected adults (including individual under guardianship by court order),

Who the study is looking for

  • Diagnosis of AD according to IWG-2 2014 criteria
  • Age 50-90 year old
  • Affiliated or beneficiary of a social security scheme
  • MMSE ≥ 20
  • Abnormal CSF Aβ42 or Aβ40/Aβ42 ratio according to local cut-offs
  • Abnormal CSF phosphorylated and total Tau according to local cut-offs
  • Ability to pass neuropsychological assessments
  • Availability of a brain MRI with T1 volumetric sequence performed within 1 year

Age in the registry: 50 years to 90 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Hôpital Cochin
Coordinator of this site? Confirm its status
ParisFranceRecruiting

This page is information, not medical advice. Discuss any trial with your doctor.